EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY-NC-ND 4.0

Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature

Lennart von Fritsch iD, Nikolas von Bubnoff iD, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.23222 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Lennart von Fritsch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Carcinoma, Acinar Cell, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic acinar cell carcinomas are rare malignant neoplasms. High‐quality evidence about the best treatment strategy is lacking. We present the case of a 52‐year‐old male with a BRAF V600E ‐mutated PACC who experienced a complete remission after chemotherapy with BRAF‐/MEK‐inhibitors. Case The patient presented with upper abdomen pain, night sweat, and weight loss. CT scan showed a pancreatic tumor extending from the pancreas head to body. Histological workup identified an acinar cell carcinoma. As the tumor was inoperable, chemotherapy with FOFIRNIOX was initiated and initially showed a slight regression of disease. The regimen had to be discontinued due to severe side effects. Molecular analysis identified a BRAF V600E mutation, so the patient was started on BRAF‐ and MEK‐inhibitors (dabrafenib/trametinib). After 16 months, CT scans showed a near complete remission with a markedly improved overall health.

Discussion

Studies suggest that up to one‐fourth of PACCs carry a BRAF mutation and might therefore be susceptible to a BRAF‐/MEK‐inhibitor therapy. This offers a new therapeutic pathway to treat this rare but malignant neoplasm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Acinar CellPancreatic NeoplasmsHumansMaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsMitogen-Activated Protein Kinase KinasesMutationProtein Kinase InhibitorsProto-Oncogene Proteins B-rafPyridonesPyrimidinones

Substanzen

BRAF protein, humanMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsProto-Oncogene Proteins B-rafPyridonesPyrimidinones

Autor:innen und Institutionen

  • Department of Surgery, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.
  • Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.
  • Luebecker Onkologische Schwerpunktpraxis, Lübeck, Germany.
  • Institute of Pathology, University Hospital Schleswig-Holstein, Campus Luebeck, Lübeck, Germany.

ORCID-Profile: Lennart von Fritsch, Nikolas von Bubnoff

Zitieren

APA

von Fritsch, L., von Bubnoff, N., Weber, K., Kirfel, J., Schreiber, C., Keck, T., & Wellner, U. (2024). Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23222

Vancouver

von Fritsch L, von Bubnoff N, Weber K, Kirfel J, Schreiber C, Keck T, et al. Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23222

BibTeX
@article{vonFritsch2024,
  author = {von Fritsch, Lennart and von Bubnoff, Nikolas and Weber, Klaus and Kirfel, Jutta and Schreiber, Cleopatra and Keck, Tobias and Wellner, Ulrich},
  title = {Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF ‐/ MEK ‐inhibitor treatment—A case report and review of the literature},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.23222}
}
Kostenlos starten →